Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study
Event:
ESC Congress 2020
Topic:
Lipid-Lowering Agents
Session:
Pharmacology and Pharmacotherapy ePosters